Kamal Hamed - Net Worth and Insider Trading

Kamal Hamed Net Worth

The estimated net worth of Kamal Hamed is at least $890,572 dollars as of 2024-11-29. Kamal Hamed is the Chief Medical Officer of Spero Therapeutics Inc and owns about 788,117 shares of Spero Therapeutics Inc (SPRO) stock worth over $890,572. Details can be seen in Kamal Hamed's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kamal Hamed has not made any transactions after 2024-02-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kamal Hamed

To

Kamal Hamed Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kamal Hamed owns 1 companies in total, including Spero Therapeutics Inc (SPRO) .

Click here to see the complete history of Kamal Hamed’s form 4 insider trades.

Insider Ownership Summary of Kamal Hamed

Ticker Comapny Transaction Date Type of Owner
SPRO Spero Therapeutics Inc 2024-02-02 Chief Medical Officer

Kamal Hamed Latest Holdings Summary

Kamal Hamed currently owns a total of 1 stock. Kamal Hamed owns 788,117 shares of Spero Therapeutics Inc (SPRO) as of February 2, 2024, with a value of $890,572.

Latest Holdings of Kamal Hamed

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SPRO Spero Therapeutics Inc 2024-02-02 788,117 1.13 890,572

Holding Weightings of Kamal Hamed


Kamal Hamed Form 4 Trading Tracker

According to the SEC Form 4 filings, Kamal Hamed has made a total of 2 transactions in Spero Therapeutics Inc (SPRO) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Spero Therapeutics Inc is the sale of 28,075 shares on February 2, 2024, which brought Kamal Hamed around $38,463.

Insider Trading History of Kamal Hamed

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kamal Hamed Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kamal Hamed Ownership Network

Ownership Network List of Kamal Hamed

No Data

Ownership Network Relation of Kamal Hamed

Insider Network Chart

Kamal Hamed Owned Company Details

What does Spero Therapeutics Inc do?

Who are the key executives at Spero Therapeutics Inc?

Kamal Hamed is the Chief Medical Officer of Spero Therapeutics Inc. Other key executives at Spero Therapeutics Inc include Chief Financial Officer Sath Shukla , director & See Remarks Ankit Mahadevia , and Chief Development Officer Timothy Keutzer .

Spero Therapeutics Inc (SPRO) Insider Trades Summary

Over the past 18 months, Kamal Hamed made 2 insider transaction in Spero Therapeutics Inc (SPRO) with a net sale of 67,571. Other recent insider transactions involving Spero Therapeutics Inc (SPRO) include a net sale of 117,209 shares made by Sath Shukla , a net sale of 78,747 shares made by Ankit Mahadevia , and a net sale of 35,038 shares made by Timothy Keutzer .

In summary, during the past 3 months, insiders sold 40,596 shares of Spero Therapeutics Inc (SPRO) in total and bought 0 shares, with a net sale of 40,596 shares. During the past 18 months, 371,921 shares of Spero Therapeutics Inc (SPRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 371,921 shares.

Spero Therapeutics Inc (SPRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Spero Therapeutics Inc Insider Transactions

No Available Data

Kamal Hamed Mailing Address

Above is the net worth, insider trading, and ownership report for Kamal Hamed. You might contact Kamal Hamed via mailing address: 675 Massachusetts Avenue, 14th Floor, Cambridge Ma 02139.

Discussions on Kamal Hamed

No discussions yet.